REFERENCES
- Medical Research Council Subcommittee: Risk of thromboembolic disease in women taking oral contraceptives. Br Med J 2: 355–359, 1967
- Herbst WP: The effects of estradiol dipropionate and diethyl stilbestrol on malignant prostatic tissue. Trans Am Assoc Genirourin Surg 34: 195–202, 1941
- Huggins C, Hodges CV: The effect of castration, of estrogen, and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1: 292–297, 1941
- Veterans Administration Cooperative Urological Research Group: Treatment and survival of patients with cancer of the prostate. Surg Gynecol Obstet 124: 1011–1017, 1967
- Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: treatment comparisons. J Urol 98: 516–522, 1967
- Blackard CE, Doe RP, Mellinger GT, et al: Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate. Cancer 26: 249–256, 1970
- Cooper JF: Estrogens and thromboembolic complications in prostatic cancer. Sixty-third annual meeting of American Urological Association, Inc., Miami Beach, May 13–16, 1968
- Kalman SM: Effects of oral contraceptives. Annu Rev Pharmacol 9: 363–378, 1969
- Coronary Drug Project Research Group: The coronary drug project: initial findings leading to modifications of its research protocol. JAMA 214: 1303–1313, 1970
- Musa BU, Seal US, Doe RP: Elevation of certain plasma proteins in man following estrogen administration: a dose-response relationship. J Clin Endocrinol Metab 25: 1163–1166, 1965
- Doe RP, Mellinger GT, Swaim WR, et al: Estrogen dosage effects on serum proteins: a longitudinal study. J Clin Endocrinol Metab 27: 1081–1086, Aug 1967
- Bailar JC III, Byar DP: Estrogen treatment for cancer of the prostate. Early results with three doses of diethylstilbestrol and placebo. Cancer 26: 257–261, 1970